News & Announcements
PR Newswire-Paragon Bioservices Wins CMO Leadership Awards
March 21, 2017
Life Science Leader Magazine Recognizes Paragon Six Years in a Rows
BALTIMORE, March 14, 2017/PRNewswire/— Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today that it has received CMO Leadership Awards for 2017. Paragon received the awards in all six of the core categories: Quality, Reliability, Capabilities, Expertise, Compatibility, and Development.
“Each year, the CMO Leadership Awards recognize the success that individual drug development and manufacturing organizations have in serving the needs of their biotechnology and pharmaceutical customers and partners,” says Louis Garguilo, Executive Editor, Life Science Leader magazine and OutsourcedPharma.com. “Recipients are evaluated by the executives and managers at the sponsors the CMOs have worked, in the 6 critical categories of capabilities, compatibility, expertise, quality, reliability and development. An award in any of these categories adds to the distinction and reputation of CMOs within the greater drug discovery, development, manufacturing and marketing industries.”
Paragon functions as a translational bridge—from the research bench through manufacturing of finished drug product for Phase I/II clinical trials. Paragon’s aim is to build strong development and manufacturing partnerships with biopharmaceutical clients, focusing on transformative technologies, including oncology immunotherapies (CAR‐T cell therapies and oncolytic viruses), new generation vaccines (VLPs) and gene therapies (AAV).
Click here to read the rest of the story